Ilan Uchitel
Co-founder & CEO
Claimed by owner CAPS Medical
Former names: Plasmed
Selective Minimally Invasive Treatment of Solid Tumors
CAPS Medical
forbes.co.il
•
Jul 18, 2021
"בדרך למהפך בטיפול בגידולים סרטניים" - Forbes Israel
www.globes.co.il
•
Jul 18, 2021
CAPS Medical גייסה 3.5 מיליון דולר לניסוי הקליני הראשון שלה
www.prnewswire.com
•
Jul 29, 2020
CAPS Medical Completes $3.5 Million Series A Round for Selective Cancer Treatment Technology
www.israel21c.org
•
Jul 12, 2020
New plasma cancer treatment kills malignant cells
www.jpost.com
•
Jan 19, 2020
https://www.jpost.com/health-science/israeli-startup-creates-new-tech-to-target-internal-solid-tumors-614397
About
CAPS Medical is a medical device company focused on the development and commercialization of its NTAP System, which uses non-thermal atmospheric plasma (NTAP) to treat a wide range of solid tumors. The minimally invasive and selective cancer treatment targets solid tumors and aims to selectively and precisely destroy only cancerous cells, leaving healthy tissue intact.
The company has demonstrated the safety and efficacy of the technology in animal studies and is nearing clinical application. Its first area of focus is non-muscle invasive bladder cancer (NMIBC). The system will then go on to address a wide range of solid tumors found in lung, liver, breast, gastrointestinal, and other cancers, for which it is on track to make a profound and needed impact.
Originally developed at the Technion - Israel Institute of Technology, the system is supported by key opinion leaders from medical fields such as oncology and interventional radiology. CAPS Medical has been supported by major shareholders Boston Scientific and MEDX Ventures Group.
The company has demonstrated the safety and efficacy of the technology in animal studies and is nearing clinical application. Its first area of focus is non-muscle invasive bladder cancer (NMIBC). The system will then go on to address a wide range of solid tumors found in lung, liver, breast, gastrointestinal, and other cancers, for which it is on track to make a profound and needed impact.
Originally developed at the Technion - Israel Institute of Technology, the system is supported by key opinion leaders from medical fields such as oncology and interventional radiology. CAPS Medical has been supported by major shareholders Boston Scientific and MEDX Ventures Group.
Employees
Product stage
Primary Sector
Life Sciences & HealthTech
Products
NTAP System
Geographic markets
-
News
(5)
forbes.co.il
•
Jul 18, 2021
"בדרך למהפך בטיפול בגידולים סרטניים" - Forbes Israel
www.globes.co.il
•
Jul 18, 2021
CAPS Medical גייסה 3.5 מיליון דולר לניסוי הקליני הראשון שלה
www.prnewswire.com
•
Jul 29, 2020
CAPS Medical Completes $3.5 Million Series A Round for Selective Cancer Treatment Technology
www.israel21c.org
•
Jul 12, 2020
New plasma cancer treatment kills malignant cells
www.jpost.com
•
Jan 19, 2020
https://www.jpost.com/health-science/israeli-startup-creates-new-tech-to-target-internal-solid-tumors-614397
The Team
(3)
BK
Boris Kogan
VP R&D
LY
Leonid Yanovitz
Director of Hardware & Physics
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Private Equity Funding
A Round
$3.5M
Jul 2020
3 Investors
$3.5M
Others
Academic Techonology
Dec 2018
undefined
Non-thermal (cold) plasma surgical device for surgical treatment deep within a body cavity
Media gallery
(1)Locations
Israel
HaMelacha Street 18, Netanya, Israel
Locations
Israel
HaMelacha Street 18, Netanya, Israel
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,